Yes, the presence of CMV can influence cancer treatment outcomes. Active CMV infection can lead to delays or interruptions in chemotherapy and other cancer treatments, potentially affecting the efficacy of these therapies. Additionally, CMV-related complications can increase morbidity and mortality in cancer patients.
